Abstract 58P
Background
Myelodysplastic syndromes (MDS) are a group of blood cancers which are characterized by ineffective hematopoiesis of bone marrow cells and abnormal blood cell development leading to cytopenias and an increased risk for progression to acute myeloid leukemia. At diagnosis, 50% of MDS patients have a normal conventional karyotype, however, unbalanced chromosomal aberrations are common and have prognostic implications. We aimed to investigate the unbalanced chromosomal aberrations in MDS patients with normal bone marrow karyotype using micro-array-based Comparative Genomic Hybridization (aCGH).
Methods
aCGH was performed on peripheral blood extracted DNA from 5 patients with clinical MDS features and normal bone marrow karyotype and we employed a Multiplex Ligation-dependent Probe Amplification (MLPA®) analysis to confirm the Subtelomeric copy number variations (CNVs).
Results
The aCGH analysis (NCBI36/hg18) revealed copy-number variations (CNV) in all patients with normal karyotype. All the 5 patients carried 16 copy-number variations (CNV), including 8 duplications ranging from 20 killobases (Kb) to 2,283 megabases (Mb), they include chromosomal regions 1q44; 2p16; 5q12, 10q27;14q12; 22q11; Xq21.3; Xq27.3 and 8 deletions ranging from 26.3 Kb to 948.9 kb, including chromosomal regions 1p36.1; 1q21; 4q31; 5p15.4; 9q21.1; 10q24; 22q21. Subtelomeric CNV (5p15; 10q27 and 1q44) were approved by using Multiplex Ligation-dependent Probe Amplification (MLPA®) analysis with SALSA MLPA Probemix P036 Subtelomeres Mix 1.
Conclusions
These results demonstrated that chromosomal defects in MDS may be more frequent than predicted by metaphase cytogenetics and new cryptic lesions may be revealed by precise analysis methods. This study suggests a significant role for the use of aCGH in the clinical workup of MDS patients.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
94P - Harnessing circulating tumor DNA in bronchoalveolar lavage fluid for precise molecular diagnosis of NSCLC
Presenter: Frank Borm
Session: Cocktail & Poster Display session
Resources:
Abstract
95P - Automatic data processing to identify EGFR mutations in pathology reports of patients with non-small cell lung cancer (NSCLC)
Presenter: Betzabel Cajiao Garcia
Session: Cocktail & Poster Display session
Resources:
Abstract
96P - Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in endometrial cancer (EC) patients
Presenter: Simona Duranti
Session: Cocktail & Poster Display session
Resources:
Abstract
97P - Prospects of liquid biopsy in determining prognosis in children with HGG and DIPG
Presenter: Olga Regentova
Session: Cocktail & Poster Display session
Resources:
Abstract
98P - Liquid biopsy in NSCLC: A promising tool to predict immunotherapy response
Presenter: Ana Fernández
Session: Cocktail & Poster Display session
Resources:
Abstract
99P - Comprehensive genomic sequencing as an ancillary diagnostic tool for pathologists
Presenter: Dan Miller
Session: Cocktail & Poster Display session
Resources:
Abstract
100P - Standard serum biomarkers to help predict a cancer diagnosis in patients with non-specific symptoms: Data from Guy´s rapid diagnostic clinic
Presenter: Maria Monroy Iglesias
Session: Cocktail & Poster Display session
Resources:
Abstract
101P - Patient-derived organoids to optimize CDK4/6 inhibitor-based treatment selection in early breast cancer
Presenter: Carla Alves
Session: Cocktail & Poster Display session
Resources:
Abstract
102P - MicroRNAs in urine and saliva as non-invasive biomarkers of minimal residual disease in pediatric acute lymphoblastic leukemia
Presenter: Alejandra Pando-Caciano
Session: Cocktail & Poster Display session
Resources:
Abstract
103P - MSI detection by NGS using tumor samples and liquid biopsy for patients with solid tumors: A single institution experience
Presenter: Alexandra Lebedeva
Session: Cocktail & Poster Display session
Resources:
Abstract